SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-018019
Filing Date
2020-07-21
Accepted
2020-07-20 20:11:55
Documents
2
Period of Report
2020-09-01
Effectiveness Date
2020-07-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0720_adialpharma.htm DEF 14A 1117188
2 GRAPHIC adial_logo1.jpg GRAPHIC 119751
  Complete submission text file 0001213900-20-018019.txt   1283245
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38323 | Film No.: 201037352
SIC: 2834 Pharmaceutical Preparations